Nicolas Fischer
Director Ejecutivo en Berta Holding AG .
Perfil
Nicolas Fischer is currently the Chief Executive Officer & Director at Coty Brasil Comércio SA and the Managing Director at Berta Holding AG.
He obtained an undergraduate degree from Technische Universität Bergakademie Freiberg.
Cargos activos de Nicolas Fischer
| Empresas | Cargo | Inicio |
|---|---|---|
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Director Ejecutivo | - |
Coty Brasil Comércio SA
 Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil. | Director Ejecutivo | - |
Formación de Nicolas Fischer.
| Technische Universität Bergakademie Freiberg | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Coty Brasil Comércio SA
Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil. | Distribution Services |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Nicolas Fischer